The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126780122 12678012 2 F 20160116 20160824 20160823 20160831 EXP FR-PFIZER INC-2016389872 PFIZER 63.00 YR M Y 76.00000 KG 20160831 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126780122 12678012 1 PS VINCRISTINE SULFATE. VINCRISTINE SULFATE 1 Intravenous drip 2 MG, DAILY (CYCLIC) 71484 2 MG
126780122 12678012 2 SS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 Intrathecal UNK 11719
126780122 12678012 3 SS DOXORUBICIN TEVA DOXORUBICIN 1 Intravenous drip 97 MG, DAILY (CYCLIC) 0 97 MG SOLUTION FOR INJECTION/INFUSION
126780122 12678012 4 SS ENDOXAN /00021101/ CYCLOPHOSPHAMIDE 1 Intravenous drip 1450 MG, DAILY (CYCLIC) 0 1450 MG
126780122 12678012 5 SS ETOPOSIDE TEVA ETOPOSIDE 1 Intravenous (not otherwise specified) 190 MG, DAILY (CYCLIC) 0 190 MG SOLUTION FOR INFUSION
126780122 12678012 6 SS METHYLPREDNISOLONE MYLAN /00049602/ METHYLPREDNISOLONE SODIUM SUCCINATE 1 Intravenous drip 100 MG, DAILY (CYCLIC) 0 100 MG
126780122 12678012 7 SS CORTANCYL PREDNISONE 1 Oral 115 MG, DAILY 0 115 MG
126780122 12678012 8 C ONDANSETRON ACCORD ONDANSETRON 1 Intravenous drip 8 MG, DAILY 0 8 MG
126780122 12678012 9 C GRANOCYTE LENOGRASTIM 1 UNK 0
126780122 12678012 10 C ZELITREX VALACYCLOVIR HYDROCHLORIDE 1 Oral 500 MG, 2X/DAY 0 500 MG BID
126780122 12678012 11 C BACTRIM SULFAMETHOXAZOLETRIMETHOPRIM 1 Oral 0
126780122 12678012 12 C LEDERFOLINE LEUCOVORIN CALCIUM 1 Oral 25 MG, WEEKLY 0 25 MG /wk
126780122 12678012 13 C ZYLORIC ALLOPURINOL 1 Oral 100 MG, 2X/DAY 0 100 MG BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126780122 12678012 10 Prophylaxis
126780122 12678012 11 Prophylaxis
126780122 12678012 12 Prophylaxis
126780122 12678012 13 Hyperuricaemia

Outcome of event

Event ID CASEID OUTC COD
126780122 12678012 DE
126780122 12678012 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126780122 12678012 Acute prerenal failure
126780122 12678012 Febrile bone marrow aplasia
126780122 12678012 Septic shock

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126780122 12678012 1 20160106 20160106 0
126780122 12678012 2 20160106 20160106 0
126780122 12678012 3 20160106 20160106 0
126780122 12678012 4 20160106 20160106 0
126780122 12678012 5 20160107 20160108 0
126780122 12678012 6 20160106 20160108 0
126780122 12678012 7 20160109 20160110 0
126780122 12678012 8 20160106 20160108 0
126780122 12678012 9 20160111 20160117 0